Alleviation of mechanical and thermal allodynia by CGRP8-37 in a rodent model of chronic central pain

Pain

Volumn 86, Issue 1-2, 2000, Pages 163-175

  Bennett, Adrianne D ^a   Chastain, Kathy M ^a   Hulsebosch, Claire E ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Allodynia; Central pain; Dorsal root ganglia; Rat; Spinal cord injury

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE[8-37];

ALLODYNIA; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; LOCOMOTION; MALE; MECHANICAL STRESS; NONHUMAN; PRIORITY JOURNAL; RAT; THERMAL EXPOSURE;

ANIMALS; BEHAVIOR, ANIMAL; CALCITONIN GENE-RELATED PEPTIDE; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; FORELIMB; HEAT; HINDLIMB; INJECTIONS, SPINAL; MALE; MOTOR ACTIVITY; PAIN; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SPINAL CORD;

EID: 0034193925     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00242-6     Document Type: Article

References (74)

1. Amara S.G., Jonas V., Rosenfeld M.G., Ong E.S., Evans R.M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 298:1982;240-244.
2. Amara S.G., Arriza J.L., Leff S.E., Swanson L.W., Evans R.M., Rosenfeld M.G. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science. 229:1985;1094-1097.
3. Basso M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1995;1-21.
4. Bennett G.J., Xie Y.K. A peripheral nonneuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
5. Biella G., Panara C., Pecile A., Sotgiu M.L. Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P (SP) and noxious stimuli in rat spinal dorsal horn neurons. An iontophoretic study in vivo. Brain Res. 559:1991;352-356.
6. Cameron A.A., Leah J.D., Snow P.J. The coexistence of neuropeptides in feline sensory neurons. Neuroscience. 27:1988;969-979.
7. Carlton S.M., Westlund K.N., Zhang D., Sorkin L., Willis W.D. Calcitonin gene-related peptide containing primary afferent fibers synapse on primate spinothalamic tract cells. Neurosci Lett. 109:1990;76-81.
8. Chatterjee T.K., Fisher R.A. Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum. Mol Pharmacol. 39:1991;798-804.
9. Chen J.J., Barber L.A., Dymshitz J., Vaski M.R. Peptidase inhibitors improve recovery of substance P and calcitonin gene-related peptide release from rat spinal cord slices. Peptides. 17:1996;31-37.
10. Chiba T., Yamaguchi A., Yamatani T., Naksmura A., Morishita T., Inui T., Fukase M., Noda T., Fujita T. Calcitonin gene-related peptide antagonist human CGRP(8-37). Am J Physiol. 256:1989;E331-E335.
11. Choi C., Yoon Y., Na H., Kim S., Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain. 59:1994;369-376.
12. Christensen M.D., Everhart A.W., Pickelman J.T., Hulsebosch C.E. Mechanical allodynia and thermal hyperalgesia in chronic central pain following spinal cord injury. Pain. 68:1996;97-107.
13. Christensen M.D., Supowit S.C., DiPette D.J., Hulsebosch C.E. Enhanced gene expression of CGRP and GAP-43 in dorsal root ganglia by spinal hemisection. J Neurotrauma. 13:1996;602.
14. Christensen M.D., Hulsebosch C.E. Chronic central pain after spinal cord injury. J Neurotrauma. 14:1997;517-537.
15. Christensen M.D., Hulsebosch C.E. Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat. Exp Neurol. 147:1997;463-475.
16. Chung K., Lee W.T., Carlton S.M. The effects of dorsal rhizotomy and spinal cord isolation on calcitonin gene related peptide labeled terminals in the rat lumbar dorsal horn. Neurosci Lett. 90:1988;27-32.
17. Cridland R.A., Henry J.L. Effects of intrathecal administration of neuropeptides on spinal nociceptive reflex in the rat: VIP, galanin, CGRP, TRH, somatostatin and angiotensin II. Neuropeptides. 11:1988;23-32.
18. Cridland R.A., Henry J.L. Intrathecal administration of CGRP in the rat attenuates a facilitation of the tail flick reflex induced by either substance P or noxious cutaneous stimulation. Neurosci Lett. 102:1989;241-246.
19. Davies S.N., Lodge D. Evidence for involvement of N-methylaspartate receptors in wind-up of class 2 neurons in the dorsal horn of the rat. Brain Res. 424:1987;402-406.
20. Dickenson A.H., Sullivan A.F. Evidence for a role of the NMDA receptor in the frequent dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology. 26:1987;1235-1238.
21. Dickenson A.H., Sullivan A.F. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat. Brain Res. 506:1990;31-39.
22. Donnerer J., Stein C. Evidence for an increase in the release of CGRP from sensory nerves during inflammation. Ann N Y Acad Sci. 657:1992;505-506.
23. Galeazza M.T., Garry M.G., Yost H.J., Strait K.A., Hargreaves K.M., Seybold V.S. Plasticity in the synthesis and storage of substance P and calcitonin gene-related peptide in primary afferent neurons during peripheral inflammation. Neuroscience. 66:1995;443-458.
24. Gamse R., Saria A. Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice. Neurosci Lett. 70:1986;143-147.
25. Gibson S.J., Polak J.M., Bloom S.R., Sabate I.M., Mulderry P.M., Ghatei M.A., McGregor G.P., Morrison J.F., Kelly J.S., Evans R.M. Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci. 4:1984;3101-3111.
26. Gray D.W., Marshall I., Bose C., Foulkes R., Hughes B. Subtypes of calcitonin gene related peptide receptor in vascular tissues. Br J Pharmacol. 102:1991;189.
27. Hargreaves K., Dubner R., Brown F., Flores D., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
28. Hökfelt T., Arvidsson U., Ceccatelli S., Cortes R., Cullheim S., Dagerlind A., Johnson H., Orazzo C., Piehl F., Pieribone V., Schalling M., Terenius L., Ulfhake B., Verge V.M., Villar M., Wiesenfeld-Hallin Z., Xu X.J., Zhang X. Calcitonin gene-related peptide in the brain, spinal cord and some peripheral systems. Ann N Y Acad Sci. 657:1992;119-133.
29. Hulsebosch C.E., Coggeshall R.E. A comparison of axonal numbers in dorsal roots following spinal cord hemisection in neonate and adult rats. Brain Res. 265:1983;187-197.
30. Ishida-Yamamoto A., Tohyama M. Calcitonin gene-related peptide in the nervous tissue. Prog Neurobiol. 33:1989;335-386.
31. Jansen-Olesen I., Mortensen A., Edvinsson L. Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalagia. 16:1996;310-316.
32. Kagstrom J., Holmgren S. Calcitonin gene-related peptide (CGRP), but not tachykinins, causes relaxation of small arteries from the rainbow trout gut. Peptides. 19:1998;577-584.
33. Kangrga I., Larew J.S.A., Randic M. The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro. Neurosci Lett. 108:1990;155-160.
34. Kawamura M., Kuraishi Y., Minami M., Satoh M. Antinociceptive effect of intrathecally administered antiserum against calcitonin gene-related peptide on thermal mechanical noxious stimuli in experimental hyperalgesic rats. Brain Res. 497:1989;199-203.
35. Krenz N.R., Weaver L.C. Sprouting of primary afferent fibers after spinal cord transection in the rat. Neuroscience. 85:1998;443-458.
36. Krenz N.R., Meakin S.O., Krassioukov A.V., Weaver L.C. Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury. J Neurosci. 19:1999;7405-7414.
37. Kuraishi Y., Nanayama T., Ohno H., Minami M., Satoh M. Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptide. Neurosci Lett. 92:1988;325-329.
38. Le Grevès P., Nyberg F., Terenius L., Hökfelt T. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur J Pharm. 115:1985;309-311.
39. Lenz F.A., Kwan H.C., Martin R., Tasker R., Richardson R.T., Dostrovsky J.O. Characteristics of somatotopic organization and spontaneous neuronal activity in the region of the thalamic principal sensory nucleus in patients with spinal cord transection. J Neurophysiol. 72:1994;1570-1587.
40. 8-37 results in a bilateral increase in hindpaw withdrawal latency in rats with a unilateral thermal injury. Neuropeptides. 31:1997;601-607.
41. Ma Q.-P., Woolf C.J. Noxious stimuli induce an N-methyl-d-aspartate receptor-dependent hypersensitivity of the flexion withdrawal reflex to touch: implication for the treatment of mechanical allodynia. Pain. 61:1995;383-390.
42. Malcangio M., Bowery N.G. Calcitonin gene-related peptide content, basal outflow and electrically-evoked release from monoarthritic rat spinal cord in vitro. Pain. 66:1996;351-358.
43. Malcangio M., Bowery N.G., Flower R.J., Perretti M. Effect of interleukin-1β on the release of substance P from rat isolated spinal cord. Eur J Pharm. 299:1996;113-118.
44. Marti E., Gibson S.J., Polak J.M., Facer P., Springall D.R., Van Aswegen G., Aitchison M., Koltzenburg M. Ontogeny of peptide- and amine-containing neurones in motor, sensory and autonomic regions of rat and human spinal cord, dorsal root ganglia and rat skin. J Comp Neurol. 266:1987;332-359.
45. McNeill D.L., Chung K., Carlton S.M., Coggeshall R.E. Calcitonin gene-related peptide immunostained axons provide evidence for fine primary afferent fibers in the dorsal and dorsolateral funiculi of the rat spinal cord. J Comp Neurol. 272:1988;303-308.
46. McNeill D.L., Carlton S.M., Hulsebosch C.E. Intraspinal sprouting of calcitonin gene-related peptide containing primary afferents after deafferentation in the rat. Exp Neurol. 114:1991;321-329.
47. Ménard D.P., van Rossum D., Kar S., Quirion R. Alteration of calcitonin gene related peptide and its receptor binding sites during the development of tolerance to μ and δ opioids. Can J Physiol Pharmacol. 73:1995;1089-1095.
48. Mendell L.M. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol. 16:1966;316-322.
49. Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain. 79:1999;1-13.
50. Miki K., Fukuoka T., Tokunaga A., Noguchi K. Calcitonin gene-related peptide increase in the rat spinal dorsal horn and dorsal column nucleus following peripheral nerve injury: upregulation in a subpopulation of primary afferent sensory neurons. Neuroscience. 82:1998;1243-1252.
51. Mulderry P.K., Ghatei M.A., Spokes R.A., Jones P.M., Pierson A.M., Hamid Q.A., Kanse S., Amara S.G., Burrin J.M., Legon S., Polak J.M., Bloom S.R. Differential expression of α-CGRP and β-CGRP by primary sensory neurones and enteric autonomic neurones of the rat. Neuroscience. 25:1988;195-205.
52. Nakamura-Craig M., Gill B.K. Effect of neurokinin A, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw. Neurosci Lett. 124:1991;49-51.
53. Neugebauer V., Rumenapp P., Schaible H.-G. Calcitonin gene-related peptide is involved in the spinal processing of mechanosensory input from the rat's knee joint and in the generation and maintenance of hyperexcitability of dorsal horn neurons during development of acute inflammation. Neuroscience. 71:1996;1095-1109.
54. Oku R., Satoh M., Fujii N., Otaka A., Yajima H., Takagi H. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res. 403:1987;350-354.
55. Parsons A.M., Seybold V.S. Calcitonin gene-related peptide induces the formation of second messengers in primary cultures of neonatal rat spinal cord. Synapse. 26:1997;235-242.
56. Perren M.J., Connor H.E., Beattie D.T. NK1 and CGRP receptor-mediated dilation of the carotid arterial bed of the anaesthetized rabbit. Neuropeptides. 30:1996;141-148.
57. Poyner D.R. Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmacol Ther. 56:1992;23-51.
58. Rosenfeld M.G., Mermod J.J., Amara S.G., Swanson L.W., Sawchenko P.E., Rivier J., Valse W.W., Evans R.M. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 304:1983;129-135.
59. Ryu P.D., Gerber G., Murase K.M., Randic M. Actions of calcitonin gene-related peptide on spinal dorsal horn neurons. Brain Res. 441:1988;357-361.
60. Satoh M., Kuraishi Y., Kawamura M. Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia: comparison with carrageenan-induced hyperalgesia. Pain. 49:1992;273-278.
61. Saxen M.A., Smith F.L., Dunlow L.D., Dombrowski D.S., Welch S.P. The hypothermic and antinociceptive effects of intrathecal injection of CGRP(8-37) in mice. Life Sci. 55:1994;1665-1674.
62. Schaible H.-G. On the role of tachykinins and calcitonin gene-related peptide in the spinal mechanisms of nociception and in the induction and maintenance of inflammation-evoked hyperexcitability in spinal cord neurons (with special reference to nociception in joints). Kumazawa T., Kruger L., Mizumura K. Progress in brain research. 113:1996;423-441 Elsevier, Amsterdam.
63. Senba E., Tohyama M. Calcitonin gene-related peptide containing autonomic efferent pathways to the pelvic ganglia of the rat. Brain Res. 449:1988;386-390.
64. Seybold V.S., Galeazza M.T., Garry M.G., Hargreaves K.M. Plasticity of calcitonin gene related peptide neurotransmission in the spinal cord during peripheral inflammation. Can J Physiol Pharmacol. 73:1995;1007-1014.
65. Tarlov I.M., Klinger H. Spinal cord compression studies. II. Time limits for recovery after acute compression in dogs. Arch Neurol Psych. 71:1954;271-290.
66. 8-37 in rat brain and peripheral tissues. J Pharm Exp Ther. 269:1994;846-853.
67. Vierck C.J. Jr. Can mechanisms of central pain syndromes be investigated in animal models? Casey K.L. Pain and central nervous system disease: the central pain syndromes. 1991;129-141 Raven Press, New York.
68. Wiesenfeld-Hallin Z., Hökfelt T., Lundberg J.M., Forssmann W.G., Reinecke M., Tschopp F.A., Fischer J.A. Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat. Neurosci Lett. 52:1984;199-204.
69. Wilcox G.L. Spinal mediators of nociceptive neurotransmission and hyperalgesia. APS J. 2:1993;265-275.
70. Willis W.D., Coggeshall R.E. Sensory mechanisms of the spinal cord. 1991;575 Plenum, New York.
71. Woolf C., Wiesenfeld-Hallin Z. Substance P and calcitonin gene-related peptide synergistically modulate the gain of the nociceptive flexor withdrawal reflex in the rat. Neurosci Lett. 66:1986;226-230.
72. Xu X.-J., Wiesenfeld-Hallin Z. Calcitonin gene-related peptide (8-37) does not antagonize calcitonin gene-related peptide in rat spinal cord. Neurosci Lett. 204:1996;185-188.
73. 8-37 increases the latency to withdrawal responses in rats. Brain Res. 653:1994;223-230.
74. 8-37 increases the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect reversed by naloxone. Neuroscience. 71:1996;523-531.